NeuroSync Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
43
- Latest Deal Type
-
Series A3
- (In Progress)
- Latest Deal Amount
-
$10M
- Investors
-
5
NeuroSync General Information
Description
Developer of a digital health platform designed for brain health and performance applications. The company's platform offers customizable technology leveraging artificial intelligence and objective measures, enabling clinicians, researchers, and high-performance specialists to utilize actionable data for identifying neurological deficits, monitoring responses to treatments, and planning targeted training programs.
Contact Information
Website
www.neurosync.healthCorporate Office
- 118 Washington Street
- Suite 14
- Holliston, MA 01746
- United States
Corporate Office
- 118 Washington Street
- Suite 14
- Holliston, MA 01746
- United States
NeuroSync Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC (Series A3) | 17-May-2023 | $10M | In Progress | Generating Revenue | ||
| 8. Later Stage VC (Series A2) | 20-Nov-2020 | Completed | Generating Revenue | |||
| 7. Debt - PPP | 15-Apr-2020 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series A1) | 10-Dec-2018 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 01-Jan-2018 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 13-Jun-2017 | Completed | Generating Revenue | |||
| 3. Seed Round | 12-Dec-2016 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 24-Oct-2014 | $1M | $1M | Completed | Pre-Clinical Trials | |
| 1. Grant | 01-Jan-2012 | $20M | Completed | Startup |
NeuroSync Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A2 | ||||||||
| Series A1 |
NeuroSync Comparisons
Industry
Financing
Details
NeuroSync Competitors (3)
One of NeuroSync’s 3 competitors is BrainScope, a Venture Capital-Backed company based in Rockville, MD.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BrainScope | Venture Capital-Backed | Rockville, MD | ||||
| Oculogica | Venture Capital-Backed | New Richmond, WI | ||||
| RightEye | Venture Capital-Backed | Bethesda, MD |
NeuroSync Patents
NeuroSync Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210219838-A1 | System and method for detection and quantification of impairment due to cannabis use | Inactive | 21-Jan-2020 | ||
| US-20160302713-A1 | System and method for concussion detection and quantification | Inactive | 15-Apr-2015 | ||
| WO-2016168724-A1 | System and method for concussion detection and quantification | Inactive | 15-Apr-2015 | ||
| US-20150208975-A1 | System and method for target independent neuromotor analytics | Inactive | 29-Jan-2014 | ||
| US-20150126899-A1 | System and method for dynamic cognitive training | Active | 06-Nov-2013 | G09B5/02 |
NeuroSync Signals
NeuroSync Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority | |||
| Mitsubishi Chemical Advanced Materials | Corporation | Minority | ||
| Oceanic Partners | Venture Capital | Minority | ||
| StartUp Health | Venture Capital | Minority | ||
| Brain Trauma Foundation | Other |
NeuroSync FAQs
-
When was NeuroSync founded?
NeuroSync was founded in 2008.
-
Where is NeuroSync headquartered?
NeuroSync is headquartered in Holliston, MA.
-
What is the size of NeuroSync?
NeuroSync has 43 total employees.
-
What industry is NeuroSync in?
NeuroSync’s primary industry is Diagnostic Equipment.
-
Is NeuroSync a private or public company?
NeuroSync is a Private company.
-
What is the current valuation of NeuroSync?
The current valuation of NeuroSync is .
-
What is NeuroSync’s current revenue?
The current revenue for NeuroSync is .
-
How much funding has NeuroSync raised over time?
NeuroSync has raised $14.5M.
-
Who are NeuroSync’s investors?
, Mitsubishi Chemical Advanced Materials, Oceanic Partners, StartUp Health, and Brain Trauma Foundation have invested in NeuroSync.
-
Who are NeuroSync’s competitors?
BrainScope, Oculogica, and RightEye are competitors of NeuroSync.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process